256 related articles for article (PubMed ID: 8756876)
1. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats.
Ellis JA; Jackson ML; Bartsch RC; McGill LG; Martin KM; Trask BR; Haines DM
J Am Vet Med Assoc; 1996 Aug; 209(4):767-71. PubMed ID: 8756876
[TBL] [Abstract][Full Text] [Related]
2. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma.
Jackson ML; Haines DM; Meric SM; Misra V
Can J Vet Res; 1993 Oct; 57(4):269-76. PubMed ID: 8269365
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
Jackson ML; Wood SL; Misra V; Haines DM
Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction.
Tandon R; Cattori V; Gomes-Keller MA; Meli ML; Golder MC; Lutz H; Hofmann-Lehmann R
J Virol Methods; 2005 Dec; 130(1-2):124-32. PubMed ID: 16054243
[TBL] [Abstract][Full Text] [Related]
5. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992).
Hendrick MJ; Shofer FS; Goldschmidt MH; Haviland JC; Schelling SH; Engler SJ; Gliatto JM
J Am Vet Med Assoc; 1994 Nov; 205(10):1425-9. PubMed ID: 7698923
[TBL] [Abstract][Full Text] [Related]
7. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
[TBL] [Abstract][Full Text] [Related]
8. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma.
Stützer B; Simon K; Lutz H; Majzoub M; Hermanns W; Hirschberger J; Sauter-Louis C; Hartmann K
J Feline Med Surg; 2011 Feb; 13(2):81-7. PubMed ID: 21131219
[TBL] [Abstract][Full Text] [Related]
9. Absolute quantitation of feline leukemia virus proviral DNA and viral RNA loads by TaqMan real-time PCR and RT-PCR.
Cattori V; Hofmann-Lehmann R
Methods Mol Biol; 2008; 429():73-87. PubMed ID: 18695960
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats.
Kass PH; Barnes WG; Spangler WL; Chomel BB; Culbertson MR
J Am Vet Med Assoc; 1993 Aug; 203(3):396-405. PubMed ID: 8257557
[TBL] [Abstract][Full Text] [Related]
11. Detection of feline leukaemia virus in blood and bone marrow of cats with varying suspicion of latent infection.
Herring ES; Troy GC; Toth TE; Forrester SD; Weigt LA; Herring IP
J Feline Med Surg; 2001 Sep; 3(3):133-41. PubMed ID: 11876630
[TBL] [Abstract][Full Text] [Related]
12. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
Grosenbaugh DA; Leard T; Pardo MC
J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
Athas GB; Choi B; Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1995 Dec; 214(2):431-8. PubMed ID: 8553544
[TBL] [Abstract][Full Text] [Related]
14. Feline leukaemia virus status of Australian cats with lymphosarcoma.
Gabor LJ; Jackson ML; Trask B; Malik R; Canfield PJ
Aust Vet J; 2001 Jul; 79(7):476-81. PubMed ID: 11549046
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphoma in a cat.
Tobey JC; Houston DM; Breur GJ; Jackson ML; Stubbington DA
J Am Vet Med Assoc; 1994 Feb; 204(4):606-9. PubMed ID: 8163416
[TBL] [Abstract][Full Text] [Related]
16. Feline leukemia virus detection in corneal tissues of cats by polymerase chain reaction and immunohistochemistry.
Herring IP; Troy GC; Toth TE; Champagne ES; Pickett JP; Haines DM
Vet Ophthalmol; 2001 Jun; 4(2):119-26. PubMed ID: 11422993
[TBL] [Abstract][Full Text] [Related]
17. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
18. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
19. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus.
Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P
Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636
[TBL] [Abstract][Full Text] [Related]
20. Two cases of FeLV-associated dermatoses.
Favrot C; Wilhelm S; Grest P; Meli ML; Hofmann-Lehmann R; Kipar A
Vet Dermatol; 2005 Dec; 16(6):407-12. PubMed ID: 16359309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]